FINNENCE ▪ THE WIRE FILE
THE WIRE · № 73624
News▼ Bearish
POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination
KINDNews
DIRECTION▼ Bearish
SOURCES1
ENTITIES3
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Nasdaq delisting determination threatens liquidity and index inclusion for the shares, pressuring holders.
Delisting risk hits small China healthcare name
CATALYST TO WATCH
Appeal outcome or Nasdaq suspension
MAIN RISK
Shares become hard to trade
FULL DISPATCH
GUANGZHOU, China, Oct. 9, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (Nasdaq: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today announced that it received a staff determination...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
A company supporting temperature-sensitive medical deliveries could join a publicly traded company in a proposed merger.2026-10-09 20:05 UTC
A company supporting temperature-sensitive medical deliveries could join a publicly traded company in a proposed merger.2026-10-09 20:05 UTC
→CORRELATIONshares Healthcare
GSK commits $800M to R&D, manufacturing hub, as Pennsylvania bonds deepen2026-10-09 20:13 UTC
GSK commits $800M to R&D, manufacturing hub, as Pennsylvania bonds deepen2026-10-09 20:13 UTC
←CORRELATIONshares ^IXIC
White & Case advises Danske Bank on the IPO and listing of Sensofusion on Nasdaq Helsinki2026-10-09 12:00 UTC
White & Case advises Danske Bank on the IPO and listing of Sensofusion on Nasdaq Helsinki2026-10-09 12:00 UTC
←CORRELATIONshares Healthcare
City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs2026-10-09 12:34 UTC
City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs2026-10-09 12:34 UTC
←CORRELATIONshares Healthcare
TRexBio, Retension raise $161.7M in IPOs; City, Iambic set proposed offering terms2026-10-09 13:42 UTC
TRexBio, Retension raise $161.7M in IPOs; City, Iambic set proposed offering terms2026-10-09 13:42 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.